Physician profile
Marc L Eckhauser
NPI 1811997513
$44,968.51
in general payments reported to CMS, 2019-2025
33 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $150 · 2021: $3,340 · 2022: $31K · 2023: $6,025 · 2024: $4,249 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,500 · Food and Beverage: $3,867 · Travel and Lodging: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,500.00 |
| Food and Beverage | $3,866.79 |
| Travel and Lodging | $1,132.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $38,599.10 | 2021-2023 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $3,396.38 | 2019-2025 | Ekosonic, General - Vascular Intervention, Varithena Administration Pack |
| Penumbra, INC. | $693.45 | 2024 | Indigo System |
| Abiomed | $381.18 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $242.41 | 2023-2025 | Lifevest |
| Biotronik INC. | $172.96 | 2022 | |
| Bard Peripheral Vascular, INC. | $148.80 | 2021 | |
| Cardiovascular Systems INC. | $148.52 | 2022-2023 | Diamondback Peripheral |
| Janssen Pharmaceuticals, INC | $137.64 | 2019-2024 | Xarelto |
| Medtronic, INC. | $109.41 | 2021-2023 | Endurant Iis, Ellipsys Vascular Access System, Turbohawk |
| Merck Sharp & Dohme LLC | $100.45 | 2024 | Verquvo |
| Tactile Systems Technology INC | $100.43 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $99.87 | 2023-2024 | Inpefa |
| Recor Medical INC | $83.14 | 2024 | Paradise Renal Denervation System |
| Novo Nordisk INC | $67.20 | 2024 | Wegovy, Rybelsus, Ozempic |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $53.59 | 2024 | Repatha |
| Pfizer INC. | $46.21 | 2024-2025 | |
| Cordis US Corp. | $44.89 | 2022-2023 | Mynx Control |
| Kiniksa Pharmaceuticals, LTD. | $40.44 | 2023 | Arcalyst |
| Biocompatibles, INC. | $34.39 | 2019 | |
| Flowphysix INC | $30.50 | 2025 | Flowrunner |
| Impulse Dynamics (USA) INC. | $29.85 | 2022-2023 | Optimizer |
| Abbott Laboratories | $29.73 | 2024 | Cardiomems |
| Cvrx, INC. | $29.42 | 2024 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $27.77 | 2023 | Assure Wcd |
| Philips North America LLC | $24.61 | 2024 | (Ck4) Mcot |
| Medtronic Vascular, INC. | $19.12 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.08 | 2024 | Jardiance |
| Cardinal Health 200 LLC | $14.07 | 2021 | |
| Azurity Pharmaceuticals, INC. | $13.63 | 2024 | Edarbi |
| Astrazeneca Pharmaceuticals LP | $12.62 | 2020 | |
| Advanced Oxygen Therapy INC. | $10.73 | 2024 | Topical Oxygen Chamber For Extremities |
| Thrombolex, INC. | $6.92 | 2024 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Eckhauser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.